SECreport
Form SC 13D/A IMMUNOMEDICS INC Filed by: SEATTLE GENETICS INC /WA
Last immunomedics earnings: 2/8 04:15 pm
Check Earnings Report
US:NASDAQ Investor Relations: immunomedics.com/2017/immunomedics-announces-presentations-investor-event-2017-san-antonio-breast-cancer-symposium
| IMPACT SNAPSHOT | EVENT TIME: | IMMU | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
IMMU alerts
IMMU alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMMU alerts
High impacting IMMUNOMEDICS news events
Weekly update
A roundup of the hottest topics
IMMU
NEWS
NEWS
- Reader Inquiry: Is There Further Upside In Immunomedics? [Seeking Alpha][Seeking Alpha]
- Immunomedics (NASDAQ: IMMU) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating.[MarketBeat]
- Immunomedics (NASDAQ: IMMU) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating.[MarketBeat]
- Immunomedics Appoints Dr. Robert Iannone Head of Research & Development and Chief Medical Officer[GlobeNewswire]
- Immunomedics, Inc. (NASDAQ: IMMU) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating.[MarketBeat]
- More
IMMU
SEC Filings
SEC Filings
- 4/19/18 - Form 8-K
- 4/13/18 - Form 8-K
- 4/10/18 - Form 8-K
- IMMU's page on the SEC website
- More